Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
19 3월 2025 - 5:00AM
Edgar (US Regulatory)
EXHIBIT I
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned
that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership
by the undersigned of the Common Stock, par value $0.001 per share, of NeoGenomics, Inc. will be filed on behalf of each of the persons
and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be
executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the
same instrument.
Dated: March 17, 2025
| |
INTEGRATED CORE STRATEGIES (US) LLC
By: Integrated Holding Group LP,
its Managing Member
By: Millennium Management LLC,
its General Partner
By: /s/ Gil Raviv
Name: Gil Raviv
Title: Global General Counsel
MILLENNIUM MANAGEMENT LLC
By: /s/ Gil Raviv
Name: Gil Raviv
Title: Global General Counsel
|
| |
MILLENNIUM GROUP MANAGEMENT LLC
By: /s/ Gil Raviv
Name: Gil Raviv
Title: Global General Counsel
/s/ Israel A. Englander
Israel A. Englander |
NeoGenomics (NASDAQ:NEO)
과거 데이터 주식 차트
부터 3월(3) 2025 으로 4월(4) 2025
NeoGenomics (NASDAQ:NEO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 4월(4) 2025
